{"abstracts-retrieval-response": {
    "item": {
        "ait:process-info": {
            "ait:status": {
                "@state": "update",
                "@type": "core",
                "@stage": "S300"
            },
            "ait:date-delivered": {
                "@day": "18",
                "@timestamp": "2022-04-18T08:28:55.000055-04:00",
                "@year": "2022",
                "@month": "04"
            },
            "ait:date-sort": {
                "@day": "01",
                "@year": "2022",
                "@month": "01"
            }
        },
        "xocs:meta": {"xocs:funding-list": {
            "@pui-match": "primary",
            "@has-funding-info": "1",
            "xocs:funding": [
                {
                    "xocs:funding-agency-matched-string": "Ratchadapisek Sompotch Foundation",
                    "xocs:funding-id": "RA63/017"
                },
                {"xocs:funding-agency-matched-string": "Thai Society of Hematology"}
            ],
            "xocs:funding-addon-generated-timestamp": "2022-02-11T00:57:15.326Z",
            "xocs:funding-text": "This study was supported by research grants from the Ratchadapisek Sompotch Foundation [RA63/017] and the Thai Society of Hematology.",
            "xocs:funding-addon-type": "http://vtw.elsevier.com/data/voc/AddOnTypes/50.7/aggregated-refined"
        }},
        "bibrecord": {
            "head": {
                "author-group": [
                    {
                        "affiliation": {
                            "country": "Thailand",
                            "@afid": "60022183",
                            "@country": "tha",
                            "city": "Bangkok",
                            "organization": [
                                {"$": "Department of Medicine"},
                                {"$": "Division of Hematology"},
                                {"$": "Faculty of Medicine"},
                                {"$": "Chulalongkorn University and King Chulalongkorn Memorial Hospital"}
                            ],
                            "affiliation-id": [
                                {
                                    "@afid": "60022183",
                                    "@dptid": "100291259"
                                },
                                {"@afid": "60028190"}
                            ],
                            "@affiliation-instance-id": "2013822451-c3165ab087b5e24784d0e9c1368c919a",
                            "ce:source-text": "Department of Medicine, Division of Hematology, Faculty of Medicine, Chulalongkorn University and King Chulalongkorn Memorial Hospital, Bangkok, Thailand",
                            "@dptid": "100291259"
                        },
                        "author": [
                            {
                                "ce:given-name": "Thunyamon",
                                "preferred-name": {
                                    "ce:given-name": "Thunyamon",
                                    "ce:initials": "T.",
                                    "ce:surname": "Chajuwan",
                                    "ce:indexed-name": "Chajuwan T."
                                },
                                "@author-instance-id": "2013822451-15365d7282881a1ce76a0efd2fd25c55",
                                "@seq": "1",
                                "ce:initials": "T.",
                                "@_fa": "true",
                                "@type": "auth",
                                "ce:surname": "Chajuwan",
                                "@auid": "57279732800",
                                "ce:indexed-name": "Chajuwan T."
                            },
                            {
                                "ce:given-name": "Patsita",
                                "preferred-name": {
                                    "ce:given-name": "Patsita",
                                    "ce:initials": "P.",
                                    "ce:surname": "Kansuwan",
                                    "ce:indexed-name": "Kansuwan P."
                                },
                                "@author-instance-id": "2013822451-4697e78b37ae1bd8654ab1f5eb401f70",
                                "@seq": "2",
                                "ce:initials": "P.",
                                "@_fa": "true",
                                "@type": "auth",
                                "ce:surname": "Kansuwan",
                                "@auid": "57278650400",
                                "ce:indexed-name": "Kansuwan P."
                            },
                            {
                                "ce:given-name": "Sirorat",
                                "preferred-name": {
                                    "ce:given-name": "Sirorat",
                                    "ce:initials": "S.",
                                    "ce:surname": "Kobbuaklee",
                                    "ce:indexed-name": "Kobbuaklee S."
                                },
                                "@author-instance-id": "2013822451-7a1e5c088984344d485268eb2bb7a574",
                                "@seq": "3",
                                "ce:initials": "S.",
                                "@_fa": "true",
                                "@type": "auth",
                                "ce:surname": "Kobbuaklee",
                                "@auid": "57211805681",
                                "ce:indexed-name": "Kobbuaklee S."
                            },
                            {
                                "ce:given-name": "Chantiya",
                                "preferred-name": {
                                    "ce:given-name": "Chantiya",
                                    "ce:initials": "C.",
                                    "ce:surname": "Chanswangphuwana",
                                    "ce:indexed-name": "Chanswangphuwana C."
                                },
                                "@author-instance-id": "2013822451-abb567efef866bb55b34e42e20b16381",
                                "@seq": "4",
                                "ce:initials": "C.",
                                "@_fa": "true",
                                "@type": "auth",
                                "ce:surname": "Chanswangphuwana",
                                "@auid": "55503235900",
                                "ce:indexed-name": "Chanswangphuwana C."
                            }
                        ]
                    },
                    {
                        "affiliation": {
                            "country": "Thailand",
                            "@afid": "60028190",
                            "@country": "tha",
                            "city": "Bangkok",
                            "organization": [
                                {"$": "Research Unit in Translational Hematology"},
                                {"$": "Chulalongkorn University"}
                            ],
                            "affiliation-id": {
                                "@afid": "60028190",
                                "@dptid": "123458373"
                            },
                            "@affiliation-instance-id": "2013822451-ea422231fb3406cc7b8a765284cad7ca",
                            "ce:source-text": "Research Unit in Translational Hematology, Chulalongkorn University, Bangkok, Thailand",
                            "@dptid": "123458373"
                        },
                        "author": [
                            {
                                "ce:given-name": "Thunyamon",
                                "preferred-name": {
                                    "ce:given-name": "Thunyamon",
                                    "ce:initials": "T.",
                                    "ce:surname": "Chajuwan",
                                    "ce:indexed-name": "Chajuwan T."
                                },
                                "@author-instance-id": "2013822451-15365d7282881a1ce76a0efd2fd25c55",
                                "@seq": "1",
                                "ce:initials": "T.",
                                "@_fa": "true",
                                "@type": "auth",
                                "ce:surname": "Chajuwan",
                                "@auid": "57279732800",
                                "ce:indexed-name": "Chajuwan T."
                            },
                            {
                                "ce:given-name": "Chantiya",
                                "preferred-name": {
                                    "ce:given-name": "Chantiya",
                                    "ce:initials": "C.",
                                    "ce:surname": "Chanswangphuwana",
                                    "ce:indexed-name": "Chanswangphuwana C."
                                },
                                "@author-instance-id": "2013822451-abb567efef866bb55b34e42e20b16381",
                                "@seq": "4",
                                "ce:initials": "C.",
                                "@_fa": "true",
                                "@type": "auth",
                                "ce:surname": "Chanswangphuwana",
                                "@auid": "55503235900",
                                "ce:indexed-name": "Chanswangphuwana C."
                            }
                        ]
                    }
                ],
                "citation-title": "Characteristics and clinical correlation of TIM-3 and PD-1/PD-L1 expressions in leukemic cells and tumor microenvironment in newly diagnosed acute myeloid leukemia",
                "abstracts": "Â© 2021 Informa UK Limited, trading as Taylor & Francis Group.Dual targeting of TIM-3 and PD-1/PD-L1 pathways is currently under investigation for cancer immunotherapy. The interaction of these immune checkpoints remains unclear in the leukemic microenvironment of acute myeloid leukemia (AML). We performed an immunophenotypic study of bone marrow in 37 newly diagnosed AML patients. High levels of TIM-3 expression on AML blasts were correlated with first 7 + 3 induction failure (CR 16.2% vs. non-CR 36.4%, p =.038). In contrast, high TIM-3 levels on natural killer (NK) cells were associated with complete remission (CR) status after induction (CR 24.7% vs. non-CR 6.5%, p =.035). Few PD-L1 positive AML blasts and PD-1 or PD-L1 positive NK cells were observed. Although the exhausted PD-1 expressing T cells were detected in 28.3% of T cells, the double positive of PD-1 and TIM-3 T cells were rarely detected. In summary, the TIM-3 levels on AML blasts and NK cells are potentially the prognostic biomarkers in AML.",
                "correspondence": {
                    "affiliation": {
                        "country": "Thailand",
                        "address-part": "Rama IV Road, Patumwan 10330",
                        "@country": "tha",
                        "city": "Bangkok",
                        "organization": [
                            {"$": "Division of Hematology"},
                            {"$": "Department of Medicine"},
                            {"$": "Faculty of Medicine"},
                            {"$": "Chulalongkorn University and King Chulalongkorn Memorial Hospital"}
                        ],
                        "ce:source-text": "Division of Hematology, Department of Medicine, Faculty of Medicine, Chulalongkorn University and King Chulalongkorn Memorial Hospital, Rama IV Road, Patumwan 10330, Bangkok, Thailand"
                    },
                    "person": {
                        "ce:given-name": "Chantiya",
                        "ce:initials": "C.",
                        "ce:surname": "Chanswangphuwana",
                        "ce:indexed-name": "Chanswangphuwana C."
                    }
                },
                "citation-info": {
                    "author-keywords": {"author-keyword": [
                        {
                            "$": "Acute myeloid leukemia",
                            "@xml:lang": "eng",
                            "@original": "y"
                        },
                        {
                            "$": "immune checkpoint",
                            "@xml:lang": "eng",
                            "@original": "y"
                        },
                        {
                            "$": "programmed cell death 1",
                            "@xml:lang": "eng",
                            "@original": "y"
                        },
                        {
                            "$": "programmed cell death ligand 1",
                            "@xml:lang": "eng",
                            "@original": "y"
                        },
                        {
                            "$": "T cell immunoglobulin and mucin-domain containing-3",
                            "@xml:lang": "eng",
                            "@original": "y"
                        }
                    ]},
                    "citation-type": {"@code": "ar"},
                    "citation-language": {
                        "@language": "English",
                        "@xml:lang": "eng"
                    },
                    "abstract-language": {
                        "@language": "English",
                        "@xml:lang": "eng"
                    }
                },
                "source": {
                    "website": {"ce:e-address": {
                        "$": "https://www.tandfonline.com/loi/ilal20",
                        "@type": "email"
                    }},
                    "translated-sourcetitle": {
                        "$": "Leukemia and Lymphoma",
                        "@xml:lang": "eng"
                    },
                    "volisspag": {
                        "voliss": {
                            "@volume": "63",
                            "@issue": "2"
                        },
                        "pagerange": {
                            "@first": "450",
                            "@last": "456"
                        }
                    },
                    "@type": "j",
                    "sourcetitle": "Leukemia and Lymphoma",
                    "publicationdate": {
                        "year": "2022",
                        "date-text": {
                            "@xfab-added": "true",
                            "$": "2022"
                        }
                    },
                    "codencode": "LELYE",
                    "sourcetitle-abbrev": "Leuk. Lymphoma",
                    "@country": "gbr",
                    "issn": [
                        {
                            "$": "10292403",
                            "@type": "electronic"
                        },
                        {
                            "$": "10428194",
                            "@type": "print"
                        }
                    ],
                    "publicationyear": {"@first": "2022"},
                    "publisher": {"publishername": "Taylor and Francis Ltd."},
                    "@srcid": "26016"
                },
                "enhancement": {
                    "classificationgroup": {"classifications": [
                        {
                            "@type": "EMCLASS",
                            "classification": [
                                {
                                    "classification-code": "16",
                                    "classification-description": "Cancer"
                                },
                                {
                                    "classification-code": "25",
                                    "classification-description": "Hematology"
                                },
                                {
                                    "classification-code": "29",
                                    "classification-description": "Clinical and Experimental Biochemistry"
                                },
                                {
                                    "classification-code": "37",
                                    "classification-description": "Drug Literature Index"
                                }
                            ]
                        },
                        {
                            "@type": "ASJC",
                            "classification": [
                                {"$": "2720"},
                                {"$": "2730"},
                                {"$": "1306"}
                            ]
                        },
                        {
                            "@type": "SUBJABBR",
                            "classification": [
                                {"$": "MEDI"},
                                {"$": "BIOC"}
                            ]
                        }
                    ]},
                    "chemicalgroup": {"chemicals": [
                        {
                            "@source": "esbd",
                            "chemical": [
                                {
                                    "cas-registry-number": [
                                        {"$": "147-94-4"},
                                        {"$": "69-74-9"}
                                    ],
                                    "chemical-name": "cytarabine"
                                },
                                {
                                    "cas-registry-number": [
                                        {"$": "57852-57-0"},
                                        {"$": "58957-92-9"}
                                    ],
                                    "chemical-name": "idarubicin"
                                }
                            ]
                        },
                        {
                            "@source": "nlm",
                            "chemical": [
                                {"chemical-name": "B7-H1 Antigen"},
                                {"chemical-name": "Hepatitis A Virus Cellular Receptor 2"},
                                {"chemical-name": "Programmed Cell Death 1 Receptor"}
                            ]
                        }
                    ]}
                },
                "grantlist": {
                    "@complete": "y",
                    "grant-text": {
                        "$": "This study was supported by research grants from the Ratchadapisek Sompotch Foundation [RA63/017] and the Thai Society of Hematology.",
                        "@xml:lang": "eng"
                    }
                }
            },
            "item-info": {
                "copyright": {
                    "$": "Copyright 2022 Elsevier B.V., All rights reserved.",
                    "@type": "Elsevier"
                },
                "external-source": "In-Data-Review",
                "dbcollection": [
                    {"$": "CABS"},
                    {"$": "EMBASE"},
                    {"$": "MEDL"},
                    {"$": "REAXYSCAR"},
                    {"$": "SCOPUS"},
                    {"$": "Scopusbase"}
                ],
                "history": {"date-created": {
                    "@day": "26",
                    "@timestamp": "BST 04:30:05",
                    "@year": "2022",
                    "@month": "02"
                }},
                "itemidlist": {
                    "itemid": [
                        {
                            "$": "2013822451",
                            "@idtype": "PUI"
                        },
                        {
                            "$": "2021401371",
                            "@idtype": "CABS"
                        },
                        {
                            "$": "935903402",
                            "@idtype": "CAR-ID"
                        },
                        {
                            "$": "20210927657",
                            "@idtype": "EMBASE"
                        },
                        {
                            "$": "34585994",
                            "@idtype": "MEDL"
                        },
                        {
                            "$": "20214155738",
                            "@idtype": "REAXYSCAR"
                        },
                        {
                            "$": "20213302843",
                            "@idtype": "SCOPUS"
                        },
                        {
                            "$": "20219007946617",
                            "@idtype": "TPA-ID"
                        },
                        {
                            "$": "85115990967",
                            "@idtype": "SCP"
                        },
                        {
                            "$": "85115990967",
                            "@idtype": "SGR"
                        },
                        {
                            "$": "636256171",
                            "@idtype": "PUIsecondary"
                        },
                        {
                            "$": "76765899",
                            "@idtype": "OSIN"
                        }
                    ],
                    "ce:doi": "10.1080/10428194.2021.1984454"
                }
            },
            "tail": {"bibliography": {
                "@refcount": "44",
                "reference": [
                    {
                        "ref-fulltext": "Nixon NA, Blais N, Ernst S, et al. Current landscape of immunotherapy in the treatment of solid tumours, with future opportunities and challenges. Curr Oncol. 2018; 25 (5): e373\u2013e384.",
                        "@id": "1",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2018"},
                            "ref-title": {"ref-titletext": "Current landscape of immunotherapy in the treatment of solid tumours, with future opportunities and challenges"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "CIT0001",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85056985064",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "25",
                                    "@issue": "5"
                                },
                                "pagerange": {
                                    "@first": "e373",
                                    "@last": "e384"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "N.A.",
                                        "@_fa": "true",
                                        "ce:surname": "Nixon",
                                        "ce:indexed-name": "Nixon N.A."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "N.",
                                        "@_fa": "true",
                                        "ce:surname": "Blais",
                                        "ce:indexed-name": "Blais N."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "S.",
                                        "@_fa": "true",
                                        "ce:surname": "Ernst",
                                        "ce:indexed-name": "Ernst S."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Curr Oncol"
                        },
                        "ce:source-text": "Nixon NA, Blais N, Ernst S, et al. Current landscape of immunotherapy in the treatment of solid tumours, with future opportunities and challenges. Curr Oncol. 2018; 25 (5): e373\u2013e384."
                    },
                    {
                        "ref-fulltext": "Zou W, Wolchok JD, Chen L. PD-L1 (B7-H1) and PD-1 pathway blockade for cancer therapy: mechanisms, response biomarkers, and combinations. Sci Transl Med. 2016; 8 (328): 328rv4.",
                        "@id": "2",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2016"},
                            "ref-title": {"ref-titletext": "PD-L1 (B7-H1) and PD-1 pathway blockade for cancer therapy: mechanisms, response biomarkers, and combinations"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "CIT0002",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "84959529731",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "8",
                                    "@issue": "328"
                                },
                                "pagerange": {"@first": "328rv4"}
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "W.",
                                    "@_fa": "true",
                                    "ce:surname": "Zou",
                                    "ce:indexed-name": "Zou W."
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "J.D.",
                                    "@_fa": "true",
                                    "ce:surname": "Wolchok",
                                    "ce:indexed-name": "Wolchok J.D."
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "L.",
                                    "@_fa": "true",
                                    "ce:surname": "Chen",
                                    "ce:indexed-name": "Chen L."
                                }
                            ]},
                            "ref-sourcetitle": "Sci Transl Med"
                        },
                        "ce:source-text": "Zou W, Wolchok JD, Chen L. PD-L1 (B7-H1) and PD-1 pathway blockade for cancer therapy: mechanisms, response biomarkers, and combinations. Sci Transl Med. 2016; 8 (328): 328rv4."
                    },
                    {
                        "ref-fulltext": "Pardoll DM. The blockade of immune checkpoints in cancer immunotherapy. Nat Rev Cancer. 2012; 12 (4): 252\u2013264.",
                        "@id": "3",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2012"},
                            "ref-title": {"ref-titletext": "The blockade of immune checkpoints in cancer immunotherapy"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "CIT0003",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "84858766182",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "12",
                                    "@issue": "4"
                                },
                                "pagerange": {
                                    "@first": "252",
                                    "@last": "264"
                                }
                            },
                            "ref-authors": {"author": [{
                                "@seq": "1",
                                "ce:initials": "D.M.",
                                "@_fa": "true",
                                "ce:surname": "Pardoll",
                                "ce:indexed-name": "Pardoll D.M."
                            }]},
                            "ref-sourcetitle": "Nat Rev Cancer"
                        },
                        "ce:source-text": "Pardoll DM. The blockade of immune checkpoints in cancer immunotherapy. Nat Rev Cancer. 2012; 12 (4): 252\u2013264."
                    },
                    {
                        "ref-fulltext": "Boddu P, Kantarjian H, Garcia-Manero G, et al. The emerging role of immune checkpoint based approaches in AML and MDS. Leuk Lymphoma. 2018; 59 (4): 790\u2013802.",
                        "@id": "4",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2018"},
                            "ref-title": {"ref-titletext": "The emerging role of immune checkpoint based approaches in AML and MDS"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "CIT0004",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85022039320",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "59",
                                    "@issue": "4"
                                },
                                "pagerange": {
                                    "@first": "790",
                                    "@last": "802"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "P.",
                                        "@_fa": "true",
                                        "ce:surname": "Boddu",
                                        "ce:indexed-name": "Boddu P."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "H.",
                                        "@_fa": "true",
                                        "ce:surname": "Kantarjian",
                                        "ce:indexed-name": "Kantarjian H."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "G.",
                                        "@_fa": "true",
                                        "ce:surname": "Garcia-Manero",
                                        "ce:indexed-name": "Garcia-Manero G."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Leuk Lymphoma"
                        },
                        "ce:source-text": "Boddu P, Kantarjian H, Garcia-Manero G, et al. The emerging role of immune checkpoint based approaches in AML and MDS. Leuk Lymphoma. 2018; 59 (4): 790\u2013802."
                    },
                    {
                        "ref-fulltext": "Zajac M, Zaleska J, Dolnik A, et al. Expression of CD274 (PD-L1) is associated with unfavourable recurrent mutations in AML. Br J Haematol. 2018; 183 (5): 822\u2013825.",
                        "@id": "5",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2018"},
                            "ref-title": {"ref-titletext": "Expression of CD274 (PD-L1) is associated with unfavourable recurrent mutations in AML"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "CIT0005",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85057462132",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "183",
                                    "@issue": "5"
                                },
                                "pagerange": {
                                    "@first": "822",
                                    "@last": "825"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "M.",
                                        "@_fa": "true",
                                        "ce:surname": "Zajac",
                                        "ce:indexed-name": "Zajac M."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "J.",
                                        "@_fa": "true",
                                        "ce:surname": "Zaleska",
                                        "ce:indexed-name": "Zaleska J."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "A.",
                                        "@_fa": "true",
                                        "ce:surname": "Dolnik",
                                        "ce:indexed-name": "Dolnik A."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Br J Haematol"
                        },
                        "ce:source-text": "Zajac M, Zaleska J, Dolnik A, et al. Expression of CD274 (PD-L1) is associated with unfavourable recurrent mutations in AML. Br J Haematol. 2018; 183 (5): 822\u2013825."
                    },
                    {
                        "ref-fulltext": "Chen X, Liu S, Wang L, et al. Clinical significance of B7-H1 (PD-L1) expression in human acute leukemia. Cancer Biol Ther. 2008; 7 (5): 622\u2013627.",
                        "@id": "6",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2008"},
                            "ref-title": {"ref-titletext": "Clinical significance of B7-H1 (PD-L1) expression in human acute leukemia"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "CIT0006",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "56149113642",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "7",
                                    "@issue": "5"
                                },
                                "pagerange": {
                                    "@first": "622",
                                    "@last": "627"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "X.",
                                        "@_fa": "true",
                                        "ce:surname": "Chen",
                                        "ce:indexed-name": "Chen X."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "S.",
                                        "@_fa": "true",
                                        "ce:surname": "Liu",
                                        "ce:indexed-name": "Liu S."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "L.",
                                        "@_fa": "true",
                                        "ce:surname": "Wang",
                                        "ce:indexed-name": "Wang L."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Cancer Biol Ther"
                        },
                        "ce:source-text": "Chen X, Liu S, Wang L, et al. Clinical significance of B7-H1 (PD-L1) expression in human acute leukemia. Cancer Biol Ther. 2008; 7 (5): 622\u2013627."
                    },
                    {
                        "ref-fulltext": "Williams P, Basu S, Garcia-Manero G, et al. The distribution of T-cell subsets and the expression of immune checkpoint receptors and ligands in patients with newly diagnosed and relapsed acute myeloid leukemia. Cancer. 2019; 125 (9): 1470\u20131481.",
                        "@id": "7",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2019"},
                            "ref-title": {"ref-titletext": "The distribution of T-cell subsets and the expression of immune checkpoint receptors and ligands in patients with newly diagnosed and relapsed acute myeloid leukemia"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "CIT0007",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85062980489",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "125",
                                    "@issue": "9"
                                },
                                "pagerange": {
                                    "@first": "1470",
                                    "@last": "1481"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "P.",
                                        "@_fa": "true",
                                        "ce:surname": "Williams",
                                        "ce:indexed-name": "Williams P."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "S.",
                                        "@_fa": "true",
                                        "ce:surname": "Basu",
                                        "ce:indexed-name": "Basu S."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "G.",
                                        "@_fa": "true",
                                        "ce:surname": "Garcia-Manero",
                                        "ce:indexed-name": "Garcia-Manero G."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Cancer"
                        },
                        "ce:source-text": "Williams P, Basu S, Garcia-Manero G, et al. The distribution of T-cell subsets and the expression of immune checkpoint receptors and ligands in patients with newly diagnosed and relapsed acute myeloid leukemia. Cancer. 2019; 125 (9): 1470\u20131481."
                    },
                    {
                        "ref-fulltext": "Mastaglio S, Wong E, Perera T, et al. Natural killer receptor ligand expression on acute myeloid leukemia impacts survival and relapse after chemotherapy. Blood Adv. 2018; 2 (4): 335\u2013346.",
                        "@id": "8",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2018"},
                            "ref-title": {"ref-titletext": "Natural killer receptor ligand expression on acute myeloid leukemia impacts survival and relapse after chemotherapy"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "CIT0008",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85055605265",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "2",
                                    "@issue": "4"
                                },
                                "pagerange": {
                                    "@first": "335",
                                    "@last": "346"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "S.",
                                        "@_fa": "true",
                                        "ce:surname": "Mastaglio",
                                        "ce:indexed-name": "Mastaglio S."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "E.",
                                        "@_fa": "true",
                                        "ce:surname": "Wong",
                                        "ce:indexed-name": "Wong E."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "T.",
                                        "@_fa": "true",
                                        "ce:surname": "Perera",
                                        "ce:indexed-name": "Perera T."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Blood Adv"
                        },
                        "ce:source-text": "Mastaglio S, Wong E, Perera T, et al. Natural killer receptor ligand expression on acute myeloid leukemia impacts survival and relapse after chemotherapy. Blood Adv. 2018; 2 (4): 335\u2013346."
                    },
                    {
                        "ref-fulltext": "Jia B, Wang L, Claxton DF, et al. Bone marrow CD8 T cells express high frequency of PD-1 and exhibit reduced anti-leukemia response in newly diagnosed AML patients. Blood Cancer J. 2018; 8 (3): 34.",
                        "@id": "9",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2018"},
                            "ref-title": {"ref-titletext": "Bone marrow CD8 T cells express high frequency of PD-1 and exhibit reduced anti-leukemia response in newly diagnosed AML patients"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "CIT0009",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85044428715",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "8",
                                    "@issue": "3"
                                },
                                "pagerange": {"@first": "34"}
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "B.",
                                        "@_fa": "true",
                                        "ce:surname": "Jia",
                                        "ce:indexed-name": "Jia B."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "L.",
                                        "@_fa": "true",
                                        "ce:surname": "Wang",
                                        "ce:indexed-name": "Wang L."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "D.F.",
                                        "@_fa": "true",
                                        "ce:surname": "Claxton",
                                        "ce:indexed-name": "Claxton D.F."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Blood Cancer J"
                        },
                        "ce:source-text": "Jia B, Wang L, Claxton DF, et al. Bone marrow CD8 T cells express high frequency of PD-1 and exhibit reduced anti-leukemia response in newly diagnosed AML patients. Blood Cancer J. 2018; 8 (3): 34."
                    },
                    {
                        "ref-fulltext": "Tan J, Yu Z, Huang J, et al. Increased PD-1 + tim-3+ exhausted T cells in bone marrow may influence the clinical outcome of patients with AML. Biomark Res. 2020; 8: 6.",
                        "@id": "10",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2020"},
                            "ref-title": {"ref-titletext": "Increased PD-1 + tim-3+ exhausted T cells in bone marrow may influence the clinical outcome of patients with AML"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "CIT0010",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85081094705",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "8"},
                                "pagerange": {"@first": "6"}
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "J.",
                                        "@_fa": "true",
                                        "ce:surname": "Tan",
                                        "ce:indexed-name": "Tan J."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "Z.",
                                        "@_fa": "true",
                                        "ce:surname": "Yu",
                                        "ce:indexed-name": "Yu Z."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "J.",
                                        "@_fa": "true",
                                        "ce:surname": "Huang",
                                        "ce:indexed-name": "Huang J."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Biomark Res"
                        },
                        "ce:source-text": "Tan J, Yu Z, Huang J, et al. Increased PD-1 + tim-3+ exhausted T cells in bone marrow may influence the clinical outcome of patients with AML. Biomark Res. 2020; 8: 6."
                    },
                    {
                        "ref-fulltext": "Dong W, Wu X, Ma S, et al. The mechanism of anti-PD-L1 antibody efficacy against PD-L1-negative tumors identifies NK cells expressing PD-L1 as a cytolytic effector. Cancer Discov. 2019; 9 (10): 1422\u20131437.",
                        "@id": "11",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2019"},
                            "ref-title": {"ref-titletext": "The mechanism of anti-PD-L1 antibody efficacy against PD-L1-negative tumors identifies NK cells expressing PD-L1 as a cytolytic effector"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "CIT0011",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85072849115",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "9",
                                    "@issue": "10"
                                },
                                "pagerange": {
                                    "@first": "1422",
                                    "@last": "1437"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "W.",
                                        "@_fa": "true",
                                        "ce:surname": "Dong",
                                        "ce:indexed-name": "Dong W."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "X.",
                                        "@_fa": "true",
                                        "ce:surname": "Wu",
                                        "ce:indexed-name": "Wu X."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "S.",
                                        "@_fa": "true",
                                        "ce:surname": "Ma",
                                        "ce:indexed-name": "Ma S."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Cancer Discov"
                        },
                        "ce:source-text": "Dong W, Wu X, Ma S, et al. The mechanism of anti-PD-L1 antibody efficacy against PD-L1-negative tumors identifies NK cells expressing PD-L1 as a cytolytic effector. Cancer Discov. 2019; 9 (10): 1422\u20131437."
                    },
                    {
                        "ref-fulltext": "Zhang L, Gajewski TF, Kline J. PD-1/PD-L1 interactions inhibit antitumor immune responses in a murine acute myeloid leukemia model. Blood. 2009; 114 (8): 1545\u20131552.",
                        "@id": "12",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2009"},
                            "ref-title": {"ref-titletext": "PD-1/PD-L1 interactions inhibit antitumor immune responses in a murine acute myeloid leukemia model"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "CIT0012",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "70349561448",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "114",
                                    "@issue": "8"
                                },
                                "pagerange": {
                                    "@first": "1545",
                                    "@last": "1552"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "L.",
                                    "@_fa": "true",
                                    "ce:surname": "Zhang",
                                    "ce:indexed-name": "Zhang L."
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "T.F.",
                                    "@_fa": "true",
                                    "ce:surname": "Gajewski",
                                    "ce:indexed-name": "Gajewski T.F."
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "J.",
                                    "@_fa": "true",
                                    "ce:surname": "Kline",
                                    "ce:indexed-name": "Kline J."
                                }
                            ]},
                            "ref-sourcetitle": "Blood"
                        },
                        "ce:source-text": "Zhang L, Gajewski TF, Kline J. PD-1/PD-L1 interactions inhibit antitumor immune responses in a murine acute myeloid leukemia model. Blood. 2009; 114 (8): 1545\u20131552."
                    },
                    {
                        "ref-fulltext": "Berger R, Rotem-Yehudar R, Slama G, et al. Phase I safety and pharmacokinetic study of CT-011, a humanized antibody interacting with PD-1, in patients with advanced hematologic malignancies. Clin Cancer Res. 2008; 14 (10): 3044\u20133051.",
                        "@id": "13",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2008"},
                            "ref-title": {"ref-titletext": "Phase I safety and pharmacokinetic study of CT-011, a humanized antibody interacting with PD-1, in patients with advanced hematologic malignancies"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "CIT0013",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "49649114804",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "14",
                                    "@issue": "10"
                                },
                                "pagerange": {
                                    "@first": "3044",
                                    "@last": "3051"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "R.",
                                        "@_fa": "true",
                                        "ce:surname": "Berger",
                                        "ce:indexed-name": "Berger R."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "R.",
                                        "@_fa": "true",
                                        "ce:surname": "Rotem-Yehudar",
                                        "ce:indexed-name": "Rotem-Yehudar R."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "G.",
                                        "@_fa": "true",
                                        "ce:surname": "Slama",
                                        "ce:indexed-name": "Slama G."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Clin Cancer Res"
                        },
                        "ce:source-text": "Berger R, Rotem-Yehudar R, Slama G, et al. Phase I safety and pharmacokinetic study of CT-011, a humanized antibody interacting with PD-1, in patients with advanced hematologic malignancies. Clin Cancer Res. 2008; 14 (10): 3044\u20133051."
                    },
                    {
                        "ref-fulltext": "Daver N, Garcia-Manero G, Basu S, et al. Efficacy, safety, and biomarkers of response to azacitidine and nivolumab in relapsed/refractory acute myeloid leukemia: a nonrandomized, open-label, phase II study. Cancer Discov. 2019; 9 (3): 370\u2013383.",
                        "@id": "14",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2019"},
                            "ref-title": {"ref-titletext": "Efficacy, safety, and biomarkers of response to azacitidine and nivolumab in relapsed/refractory acute myeloid leukemia: a nonrandomized, open-label, phase II study"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "CIT0014",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85063596016",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "9",
                                    "@issue": "3"
                                },
                                "pagerange": {
                                    "@first": "370",
                                    "@last": "383"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "N.",
                                        "@_fa": "true",
                                        "ce:surname": "Daver",
                                        "ce:indexed-name": "Daver N."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "G.",
                                        "@_fa": "true",
                                        "ce:surname": "Garcia-Manero",
                                        "ce:indexed-name": "Garcia-Manero G."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "S.",
                                        "@_fa": "true",
                                        "ce:surname": "Basu",
                                        "ce:indexed-name": "Basu S."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Cancer Discov"
                        },
                        "ce:source-text": "Daver N, Garcia-Manero G, Basu S, et al. Efficacy, safety, and biomarkers of response to azacitidine and nivolumab in relapsed/refractory acute myeloid leukemia: a nonrandomized, open-label, phase II study. Cancer Discov. 2019; 9 (3): 370\u2013383."
                    },
                    {
                        "ref-fulltext": "Das M, Zhu C, Kuchroo VK. Tim-3 and its role in regulating anti-tumor immunity. Immunol Rev. 2017; 276 (1): 97\u2013111.",
                        "@id": "15",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2017"},
                            "ref-title": {"ref-titletext": "Tim-3 and its role in regulating anti-tumor immunity"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "CIT0015",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85014339330",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "276",
                                    "@issue": "1"
                                },
                                "pagerange": {
                                    "@first": "97",
                                    "@last": "111"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "M.",
                                    "@_fa": "true",
                                    "ce:surname": "Das",
                                    "ce:indexed-name": "Das M."
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "C.",
                                    "@_fa": "true",
                                    "ce:surname": "Zhu",
                                    "ce:indexed-name": "Zhu C."
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "V.K.",
                                    "@_fa": "true",
                                    "ce:surname": "Kuchroo",
                                    "ce:indexed-name": "Kuchroo V.K."
                                }
                            ]},
                            "ref-sourcetitle": "Immunol Rev"
                        },
                        "ce:source-text": "Das M, Zhu C, Kuchroo VK. Tim-3 and its role in regulating anti-tumor immunity. Immunol Rev. 2017; 276 (1): 97\u2013111."
                    },
                    {
                        "ref-fulltext": "Wolf Y, Anderson AC, Kuchroo VK. TIM3 comes of age as an inhibitory receptor. Nat Rev Immunol. 2020; 20 (3): 173\u2013185.",
                        "@id": "16",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2020"},
                            "ref-title": {"ref-titletext": "TIM3 comes of age as an inhibitory receptor"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "CIT0016",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85074837193",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "20",
                                    "@issue": "3"
                                },
                                "pagerange": {
                                    "@first": "173",
                                    "@last": "185"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "Y.",
                                    "@_fa": "true",
                                    "ce:surname": "Wolf",
                                    "ce:indexed-name": "Wolf Y."
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "A.C.",
                                    "@_fa": "true",
                                    "ce:surname": "Anderson",
                                    "ce:indexed-name": "Anderson A.C."
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "V.K.",
                                    "@_fa": "true",
                                    "ce:surname": "Kuchroo",
                                    "ce:indexed-name": "Kuchroo V.K."
                                }
                            ]},
                            "ref-sourcetitle": "Nat Rev Immunol"
                        },
                        "ce:source-text": "Wolf Y, Anderson AC, Kuchroo VK. TIM3 comes of age as an inhibitory receptor. Nat Rev Immunol. 2020; 20 (3): 173\u2013185."
                    },
                    {
                        "ref-fulltext": "Dama P, Tang M, Fulton N, et al. Gal9/tim-3 expression level is higher in AML patients who fail chemotherapy. J Immunother Cancer. 2019; 7 (1): 175.",
                        "@id": "17",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2019"},
                            "ref-title": {"ref-titletext": "Gal9/tim-3 expression level is higher in AML patients who fail chemotherapy"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "CIT0017",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85068911170",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "7",
                                    "@issue": "1"
                                },
                                "pagerange": {"@first": "175"}
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "P.",
                                        "@_fa": "true",
                                        "ce:surname": "Dama",
                                        "ce:indexed-name": "Dama P."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "M.",
                                        "@_fa": "true",
                                        "ce:surname": "Tang",
                                        "ce:indexed-name": "Tang M."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "N.",
                                        "@_fa": "true",
                                        "ce:surname": "Fulton",
                                        "ce:indexed-name": "Fulton N."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "J Immunother Cancer"
                        },
                        "ce:source-text": "Dama P, Tang M, Fulton N, et al. Gal9/tim-3 expression level is higher in AML patients who fail chemotherapy. J Immunother Cancer. 2019; 7 (1): 175."
                    },
                    {
                        "ref-fulltext": "Tan J, Huang S, Huang J, et al. Increasing tim-3 + CD244+, tim-3 + CD57+, and tim-3 + PD-1+ T cells in patients with acute myeloid leukemia. Asia Pac J Clin Oncol. 2020; 16 (3): 137\u2013141.",
                        "@id": "18",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2020"},
                            "ref-title": {"ref-titletext": "Increasing tim-3 + CD244+, tim-3 + CD57+, and tim-3 + PD-1+ T cells in patients with acute myeloid leukemia"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "CIT0018",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85079199258",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "16",
                                    "@issue": "3"
                                },
                                "pagerange": {
                                    "@first": "137",
                                    "@last": "141"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "J.",
                                        "@_fa": "true",
                                        "ce:surname": "Tan",
                                        "ce:indexed-name": "Tan J."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "S.",
                                        "@_fa": "true",
                                        "ce:surname": "Huang",
                                        "ce:indexed-name": "Huang S."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "J.",
                                        "@_fa": "true",
                                        "ce:surname": "Huang",
                                        "ce:indexed-name": "Huang J."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Asia Pac J Clin Oncol"
                        },
                        "ce:source-text": "Tan J, Huang S, Huang J, et al. Increasing tim-3 + CD244+, tim-3 + CD57+, and tim-3 + PD-1+ T cells in patients with acute myeloid leukemia. Asia Pac J Clin Oncol. 2020; 16 (3): 137\u2013141."
                    },
                    {
                        "ref-fulltext": "Li C, Chen X, Yu X, et al. Tim-3 is highly expressed in T cells in acute myeloid leukemia and associated with clinicopathological prognostic stratification. Int J Clin Exp Pathol. 2014; 7 (10): 6880\u20136888.",
                        "@id": "19",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2014"},
                            "ref-title": {"ref-titletext": "Tim-3 is highly expressed in T cells in acute myeloid leukemia and associated with clinicopathological prognostic stratification"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "CIT0019",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "84912120225",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "7",
                                    "@issue": "10"
                                },
                                "pagerange": {
                                    "@first": "6880",
                                    "@last": "6888"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "C.",
                                        "@_fa": "true",
                                        "ce:surname": "Li",
                                        "ce:indexed-name": "Li C."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "X.",
                                        "@_fa": "true",
                                        "ce:surname": "Chen",
                                        "ce:indexed-name": "Chen X."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "X.",
                                        "@_fa": "true",
                                        "ce:surname": "Yu",
                                        "ce:indexed-name": "Yu X."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Int J Clin Exp Pathol"
                        },
                        "ce:source-text": "Li C, Chen X, Yu X, et al. Tim-3 is highly expressed in T cells in acute myeloid leukemia and associated with clinicopathological prognostic stratification. Int J Clin Exp Pathol. 2014; 7 (10): 6880\u20136888."
                    },
                    {
                        "ref-fulltext": "Haubner S, Perna F, KÃ¶hnke T, et al. Coexpression profile of leukemic stem cell markers for combinatorial targeted therapy in AML. Leukemia. 2019; 33 (1): 64\u201374.",
                        "@id": "20",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2019"},
                            "ref-title": {"ref-titletext": "Coexpression profile of leukemic stem cell markers for combinatorial targeted therapy in AML"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "CIT0020",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85049073728",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "33",
                                    "@issue": "1"
                                },
                                "pagerange": {
                                    "@first": "64",
                                    "@last": "74"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "S.",
                                        "@_fa": "true",
                                        "ce:surname": "Haubner",
                                        "ce:indexed-name": "Haubner S."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "F.",
                                        "@_fa": "true",
                                        "ce:surname": "Perna",
                                        "ce:indexed-name": "Perna F."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "T.",
                                        "@_fa": "true",
                                        "ce:surname": "KÃ¶hnke",
                                        "ce:indexed-name": "Kohnke T."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Leukemia"
                        },
                        "ce:source-text": "Haubner S, Perna F, KÃ¶hnke T, et al. Coexpression profile of leukemic stem cell markers for combinatorial targeted therapy in AML. Leukemia. 2019; 33 (1): 64\u201374."
                    },
                    {
                        "ref-fulltext": "Darwish NHE, Sudha T, Godugu K, et al. Acute myeloid leukemia stem cell markers in prognosis and targeted therapy: potential impact of BMI-1, TIM-3 and CLL-1. Oncotarget. 2016; 7 (36): 57811\u201357820.",
                        "@id": "21",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2016"},
                            "ref-title": {"ref-titletext": "Acute myeloid leukemia stem cell markers in prognosis and targeted therapy: potential impact of BMI-1, TIM-3 and CLL-1"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "CIT0021",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "84988432693",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "7",
                                    "@issue": "36"
                                },
                                "pagerange": {
                                    "@first": "57811",
                                    "@last": "57820"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "N.H.E.",
                                        "@_fa": "true",
                                        "ce:surname": "Darwish",
                                        "ce:indexed-name": "Darwish N.H.E."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "T.",
                                        "@_fa": "true",
                                        "ce:surname": "Sudha",
                                        "ce:indexed-name": "Sudha T."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "K.",
                                        "@_fa": "true",
                                        "ce:surname": "Godugu",
                                        "ce:indexed-name": "Godugu K."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Oncotarget"
                        },
                        "ce:source-text": "Darwish NHE, Sudha T, Godugu K, et al. Acute myeloid leukemia stem cell markers in prognosis and targeted therapy: potential impact of BMI-1, TIM-3 and CLL-1. Oncotarget. 2016; 7 (36): 57811\u201357820."
                    },
                    {
                        "ref-fulltext": "GonÃ§alves Silva I, Gibbs BF, Bardelli M, et al. Differential expression and biochemical activity of the immune receptor tim-3 in healthy and malignant human myeloid cells. Oncotarget. 2015; 6 (32): 33823\u201333833.",
                        "@id": "22",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2015"},
                            "ref-title": {"ref-titletext": "Differential expression and biochemical activity of the immune receptor tim-3 in healthy and malignant human myeloid cells"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "CIT0022",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "84946017988",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "6",
                                    "@issue": "32"
                                },
                                "pagerange": {
                                    "@first": "33823",
                                    "@last": "33833"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "I.",
                                        "@_fa": "true",
                                        "ce:surname": "GonÃ§alves Silva",
                                        "ce:indexed-name": "Goncalves Silva I."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "B.F.",
                                        "@_fa": "true",
                                        "ce:surname": "Gibbs",
                                        "ce:indexed-name": "Gibbs B.F."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "M.",
                                        "@_fa": "true",
                                        "ce:surname": "Bardelli",
                                        "ce:indexed-name": "Bardelli M."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Oncotarget"
                        },
                        "ce:source-text": "GonÃ§alves Silva I, Gibbs BF, Bardelli M, et al. Differential expression and biochemical activity of the immune receptor tim-3 in healthy and malignant human myeloid cells. Oncotarget. 2015; 6 (32): 33823\u201333833."
                    },
                    {
                        "ref-fulltext": "Kikushige Y, Miyamoto T, Yuda J, et al. A TIM-3/gal-9 autocrine stimulatory loop drives self-renewal of human myeloid leukemia stem cells and leukemic progression. Cell Stem Cell. 2015; 17 (3): 341\u2013352.",
                        "@id": "23",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2015"},
                            "ref-title": {"ref-titletext": "A TIM-3/gal-9 autocrine stimulatory loop drives self-renewal of human myeloid leukemia stem cells and leukemic progression"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "CIT0023",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "84941023046",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "17",
                                    "@issue": "3"
                                },
                                "pagerange": {
                                    "@first": "341",
                                    "@last": "352"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "Y.",
                                        "@_fa": "true",
                                        "ce:surname": "Kikushige",
                                        "ce:indexed-name": "Kikushige Y."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "T.",
                                        "@_fa": "true",
                                        "ce:surname": "Miyamoto",
                                        "ce:indexed-name": "Miyamoto T."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "J.",
                                        "@_fa": "true",
                                        "ce:surname": "Yuda",
                                        "ce:indexed-name": "Yuda J."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Cell Stem Cell"
                        },
                        "ce:source-text": "Kikushige Y, Miyamoto T, Yuda J, et al. A TIM-3/gal-9 autocrine stimulatory loop drives self-renewal of human myeloid leukemia stem cells and leukemic progression. Cell Stem Cell. 2015; 17 (3): 341\u2013352."
                    },
                    {
                        "ref-fulltext": "GonÃ§alves Silva I, Yasinska IM, Sakhnevych SS, et al. The tim-3-galectin-9 secretory pathway is involved in the immune escape of human acute myeloid leukemia cells. EBioMedicine. 2017; 22: 44\u201357.",
                        "@id": "24",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2017"},
                            "ref-title": {"ref-titletext": "The tim-3-galectin-9 secretory pathway is involved in the immune escape of human acute myeloid leukemia cells"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "CIT0024",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85025473665",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "22"},
                                "pagerange": {
                                    "@first": "44",
                                    "@last": "57"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "I.",
                                        "@_fa": "true",
                                        "ce:surname": "GonÃ§alves Silva",
                                        "ce:indexed-name": "Goncalves Silva I."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "I.M.",
                                        "@_fa": "true",
                                        "ce:surname": "Yasinska",
                                        "ce:indexed-name": "Yasinska I.M."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "S.S.",
                                        "@_fa": "true",
                                        "ce:surname": "Sakhnevych",
                                        "ce:indexed-name": "Sakhnevych S.S."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "EBioMedicine"
                        },
                        "ce:source-text": "GonÃ§alves Silva I, Yasinska IM, Sakhnevych SS, et al. The tim-3-galectin-9 secretory pathway is involved in the immune escape of human acute myeloid leukemia cells. EBioMedicine. 2017; 22: 44\u201357."
                    },
                    {
                        "ref-fulltext": "Kikushige Y, Shima T, Takayanagi S, et al. TIM-3 is a promising target to selectively kill acute myeloid leukemia stem cells. Cell Stem Cell. 2010; 7 (6): 708\u2013717.",
                        "@id": "25",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2010"},
                            "ref-title": {"ref-titletext": "TIM-3 is a promising target to selectively kill acute myeloid leukemia stem cells"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "CIT0025",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "78649686241",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "7",
                                    "@issue": "6"
                                },
                                "pagerange": {
                                    "@first": "708",
                                    "@last": "717"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "Y.",
                                        "@_fa": "true",
                                        "ce:surname": "Kikushige",
                                        "ce:indexed-name": "Kikushige Y."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "T.",
                                        "@_fa": "true",
                                        "ce:surname": "Shima",
                                        "ce:indexed-name": "Shima T."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "S.",
                                        "@_fa": "true",
                                        "ce:surname": "Takayanagi",
                                        "ce:indexed-name": "Takayanagi S."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Cell Stem Cell"
                        },
                        "ce:source-text": "Kikushige Y, Shima T, Takayanagi S, et al. TIM-3 is a promising target to selectively kill acute myeloid leukemia stem cells. Cell Stem Cell. 2010; 7 (6): 708\u2013717."
                    },
                    {
                        "ref-fulltext": "Kikushige Y, Miyamoto T. TIM-3 as a novel therapeutic target for eradicating acute myelogenous leukemia stem cells. Int J Hematol. 2013; 98 (6): 627\u2013633.",
                        "@id": "26",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2013"},
                            "ref-title": {"ref-titletext": "TIM-3 as a novel therapeutic target for eradicating acute myelogenous leukemia stem cells"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "CIT0026",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "84891145768",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "98",
                                    "@issue": "6"
                                },
                                "pagerange": {
                                    "@first": "627",
                                    "@last": "633"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "Y.",
                                    "@_fa": "true",
                                    "ce:surname": "Kikushige",
                                    "ce:indexed-name": "Kikushige Y."
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "T.",
                                    "@_fa": "true",
                                    "ce:surname": "Miyamoto",
                                    "ce:indexed-name": "Miyamoto T."
                                }
                            ]},
                            "ref-sourcetitle": "Int J Hematol"
                        },
                        "ce:source-text": "Kikushige Y, Miyamoto T. TIM-3 as a novel therapeutic target for eradicating acute myelogenous leukemia stem cells. Int J Hematol. 2013; 98 (6): 627\u2013633."
                    },
                    {
                        "ref-fulltext": "Acharya N, Sabatos-Peyton C, Anderson AC. Tim-3 finds its place in the cancer immunotherapy landscape. J Immunother Cancer. 2020; 8 (1): e000911.",
                        "@id": "27",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2020"},
                            "ref-title": {"ref-titletext": "Tim-3 finds its place in the cancer immunotherapy landscape"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "CIT0027",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85087387520",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "8",
                                    "@issue": "1"
                                },
                                "pagerange": {"@first": "e000911"}
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "N.",
                                    "@_fa": "true",
                                    "ce:surname": "Acharya",
                                    "ce:indexed-name": "Acharya N."
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "C.",
                                    "@_fa": "true",
                                    "ce:surname": "Sabatos-Peyton",
                                    "ce:indexed-name": "Sabatos-Peyton C."
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "A.C.",
                                    "@_fa": "true",
                                    "ce:surname": "Anderson",
                                    "ce:indexed-name": "Anderson A.C."
                                }
                            ]},
                            "ref-sourcetitle": "J Immunother Cancer"
                        },
                        "ce:source-text": "Acharya N, Sabatos-Peyton C, Anderson AC. Tim-3 finds its place in the cancer immunotherapy landscape. J Immunother Cancer. 2020; 8 (1): e000911."
                    },
                    {
                        "ref-fulltext": "Wang Z, Chen J, Wang M, et al. One stone, two birds: the roles of tim-3 in acute myeloid leukemia. Front Immunol. 2021; 12: 618710.",
                        "@id": "28",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2021"},
                            "ref-title": {"ref-titletext": "One stone, two birds: the roles of tim-3 in acute myeloid leukemia"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "CIT0028",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85104262449",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "12"},
                                "pagerange": {"@first": "618710"}
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "Z.",
                                        "@_fa": "true",
                                        "ce:surname": "Wang",
                                        "ce:indexed-name": "Wang Z."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "J.",
                                        "@_fa": "true",
                                        "ce:surname": "Chen",
                                        "ce:indexed-name": "Chen J."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "M.",
                                        "@_fa": "true",
                                        "ce:surname": "Wang",
                                        "ce:indexed-name": "Wang M."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Front Immunol"
                        },
                        "ce:source-text": "Wang Z, Chen J, Wang M, et al. One stone, two birds: the roles of tim-3 in acute myeloid leukemia. Front Immunol. 2021; 12: 618710."
                    },
                    {
                        "ref-fulltext": "Gleason MK, Lenvik TR, McCullar V, et al. Tim-3 is an inducible human natural killer cell receptor that enhances interferon gamma production in response to galectin-9. Blood. 2012; 119 (13): 3064\u20133072.",
                        "@id": "29",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2012"},
                            "ref-title": {"ref-titletext": "Tim-3 is an inducible human natural killer cell receptor that enhances interferon gamma production in response to galectin-9"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "CIT0029",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "84859192882",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "119",
                                    "@issue": "13"
                                },
                                "pagerange": {
                                    "@first": "3064",
                                    "@last": "3072"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "M.K.",
                                        "@_fa": "true",
                                        "ce:surname": "Gleason",
                                        "ce:indexed-name": "Gleason M.K."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "T.R.",
                                        "@_fa": "true",
                                        "ce:surname": "Lenvik",
                                        "ce:indexed-name": "Lenvik T.R."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "V.",
                                        "@_fa": "true",
                                        "ce:surname": "McCullar",
                                        "ce:indexed-name": "McCullar V."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Blood"
                        },
                        "ce:source-text": "Gleason MK, Lenvik TR, McCullar V, et al. Tim-3 is an inducible human natural killer cell receptor that enhances interferon gamma production in response to galectin-9. Blood. 2012; 119 (13): 3064\u20133072."
                    },
                    {
                        "ref-fulltext": "Ndhlovu LC, Lopez-VergÃ¨s S, Barbour JD, et al. Tim-3 marks human natural killer cell maturation and suppresses cell-mediated cytotoxicity. Blood. 2012; 119 (16): 3734\u20133743.",
                        "@id": "30",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2012"},
                            "ref-title": {"ref-titletext": "Tim-3 marks human natural killer cell maturation and suppresses cell-mediated cytotoxicity"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "CIT0030",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "84860337409",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "119",
                                    "@issue": "16"
                                },
                                "pagerange": {
                                    "@first": "3734",
                                    "@last": "3743"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "L.C.",
                                        "@_fa": "true",
                                        "ce:surname": "Ndhlovu",
                                        "ce:indexed-name": "Ndhlovu L.C."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "S.",
                                        "@_fa": "true",
                                        "ce:surname": "Lopez-VergÃ¨s",
                                        "ce:indexed-name": "Lopez-Verges S."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "J.D.",
                                        "@_fa": "true",
                                        "ce:surname": "Barbour",
                                        "ce:indexed-name": "Barbour J.D."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Blood"
                        },
                        "ce:source-text": "Ndhlovu LC, Lopez-VergÃ¨s S, Barbour JD, et al. Tim-3 marks human natural killer cell maturation and suppresses cell-mediated cytotoxicity. Blood. 2012; 119 (16): 3734\u20133743."
                    },
                    {
                        "ref-fulltext": "Dao TN, Utturkar S, Lanman NA, et al. TIM-3 expression is downregulated on human NK cells in response to cancer targets in synergy with activation. Cancers (Basel). 2020; 12 (9): 2417.",
                        "@id": "31",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2020"},
                            "ref-title": {"ref-titletext": "TIM-3 expression is downregulated on human NK cells in response to cancer targets in synergy with activation"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "CIT0031",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85089838388",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "12",
                                    "@issue": "9"
                                },
                                "pagerange": {"@first": "2417"}
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "T.N.",
                                        "@_fa": "true",
                                        "ce:surname": "Dao",
                                        "ce:indexed-name": "Dao T.N."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "S.",
                                        "@_fa": "true",
                                        "ce:surname": "Utturkar",
                                        "ce:indexed-name": "Utturkar S."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "N.A.",
                                        "@_fa": "true",
                                        "ce:surname": "Lanman",
                                        "ce:indexed-name": "Lanman N.A."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Cancers (Basel)"
                        },
                        "ce:source-text": "Dao TN, Utturkar S, Lanman NA, et al. TIM-3 expression is downregulated on human NK cells in response to cancer targets in synergy with activation. Cancers (Basel). 2020; 12 (9): 2417."
                    },
                    {
                        "ref-fulltext": "Folgiero V, Cifaldi L, Pira GL, et al. TIM-3/gal-9 interaction induces IFNÎ³-dependent IDO1 expression in acute myeloid leukemia blast cells. J Hematol Oncol. 2015; 8: 36.",
                        "@id": "32",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2015"},
                            "ref-title": {"ref-titletext": "TIM-3/gal-9 interaction induces IFNÎ³-dependent IDO1 expression in acute myeloid leukemia blast cells"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "CIT0032",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85018126461",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "8"},
                                "pagerange": {"@first": "36"}
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "V.",
                                        "@_fa": "true",
                                        "ce:surname": "Folgiero",
                                        "ce:indexed-name": "Folgiero V."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "L.",
                                        "@_fa": "true",
                                        "ce:surname": "Cifaldi",
                                        "ce:indexed-name": "Cifaldi L."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "G.L.",
                                        "@_fa": "true",
                                        "ce:surname": "Pira",
                                        "ce:indexed-name": "Pira G.L."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "J Hematol Oncol"
                        },
                        "ce:source-text": "Folgiero V, Cifaldi L, Pira GL, et al. TIM-3/gal-9 interaction induces IFNÎ³-dependent IDO1 expression in acute myeloid leukemia blast cells. J Hematol Oncol. 2015; 8: 36."
                    },
                    {
                        "ref-fulltext": "DÃ¶hner H, Estey E, Grimwade D, et al. Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel. Blood. 2017; 129 (4): 424\u2013447.",
                        "@id": "33",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2017"},
                            "ref-title": {"ref-titletext": "Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "CIT0033",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85014879329",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "129",
                                    "@issue": "4"
                                },
                                "pagerange": {
                                    "@first": "424",
                                    "@last": "447"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "H.",
                                        "@_fa": "true",
                                        "ce:surname": "DÃ¶hner",
                                        "ce:indexed-name": "Dohner H."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "E.",
                                        "@_fa": "true",
                                        "ce:surname": "Estey",
                                        "ce:indexed-name": "Estey E."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "D.",
                                        "@_fa": "true",
                                        "ce:surname": "Grimwade",
                                        "ce:indexed-name": "Grimwade D."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Blood"
                        },
                        "ce:source-text": "DÃ¶hner H, Estey E, Grimwade D, et al. Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel. Blood. 2017; 129 (4): 424\u2013447."
                    },
                    {
                        "ref-fulltext": "Arber DA, Vardiman JW, Brunning RD, et al. Acute myeloid leukaemia and related precursor neoplasm. In: Swerdlow S, Campo E, Harris NL, Pileri SA, Jaffe E, Stein H, Thiele J, editors. World health organization classification of tumours of haematopoietic and lymphoid tissues. 4th ed. Lyon: World Health Organization; 2017. p. 129\u2013172.",
                        "@id": "34",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2017"},
                            "ref-title": {"ref-titletext": "Acute myeloid leukaemia and related precursor neoplasm"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "CIT0034",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "67649431530",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {"pagerange": {
                                "@first": "129",
                                "@last": "172"
                            }},
                            "ref-text": "Swerdlow S., Campo E., Harris N.L., Pileri S.A., Jaffe E., Stein H., Thiele J., (eds), Lyon: World Health Organization,. In:, editors.,. 4th ed.,. p",
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "D.A.",
                                        "@_fa": "true",
                                        "ce:surname": "Arber",
                                        "ce:indexed-name": "Arber D.A."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "J.W.",
                                        "@_fa": "true",
                                        "ce:surname": "Vardiman",
                                        "ce:indexed-name": "Vardiman J.W."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "R.D.",
                                        "@_fa": "true",
                                        "ce:surname": "Brunning",
                                        "ce:indexed-name": "Brunning R.D."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "World health organization classification of tumours of haematopoietic and lymphoid tissues"
                        },
                        "ce:source-text": "Arber DA, Vardiman JW, Brunning RD, et al. Acute myeloid leukaemia and related precursor neoplasm. In: Swerdlow S, Campo E, Harris NL, Pileri SA, Jaffe E, Stein H, Thiele J, editors. World health organization classification of tumours of haematopoietic and lymphoid tissues. 4th ed. Lyon: World Health Organization; 2017. p. 129\u2013172."
                    },
                    {
                        "ref-fulltext": "Rakova J, Truxova I, Holicek P, et al. TIM-3 levels correlate with enhanced NK cell cytotoxicity and improved clinical outcome in AML patients. Oncoimmunology. 2021; 10 (1): 1889822.",
                        "@id": "35",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2021"},
                            "ref-title": {"ref-titletext": "TIM-3 levels correlate with enhanced NK cell cytotoxicity and improved clinical outcome in AML patients"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "CIT0035",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85102181179",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "10",
                                    "@issue": "1"
                                },
                                "pagerange": {"@first": "1889822"}
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "J.",
                                        "@_fa": "true",
                                        "ce:surname": "Rakova",
                                        "ce:indexed-name": "Rakova J."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "I.",
                                        "@_fa": "true",
                                        "ce:surname": "Truxova",
                                        "ce:indexed-name": "Truxova I."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "P.",
                                        "@_fa": "true",
                                        "ce:surname": "Holicek",
                                        "ce:indexed-name": "Holicek P."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Oncoimmunology"
                        },
                        "ce:source-text": "Rakova J, Truxova I, Holicek P, et al. TIM-3 levels correlate with enhanced NK cell cytotoxicity and improved clinical outcome in AML patients. Oncoimmunology. 2021; 10 (1): 1889822."
                    },
                    {
                        "ref-fulltext": "Yang C, Siebert JR, Burns R, et al. Heterogeneity of human bone marrow and blood natural killer cells defined by single-cell transcriptome. Nat Commun. 2019; 10 (1): 3931.",
                        "@id": "36",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2019"},
                            "ref-title": {"ref-titletext": "Heterogeneity of human bone marrow and blood natural killer cells defined by single-cell transcriptome"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "CIT0036",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85071610251",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "10",
                                    "@issue": "1"
                                },
                                "pagerange": {"@first": "3931"}
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "C.",
                                        "@_fa": "true",
                                        "ce:surname": "Yang",
                                        "ce:indexed-name": "Yang C."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "J.R.",
                                        "@_fa": "true",
                                        "ce:surname": "Siebert",
                                        "ce:indexed-name": "Siebert J.R."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "R.",
                                        "@_fa": "true",
                                        "ce:surname": "Burns",
                                        "ce:indexed-name": "Burns R."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Nat Commun"
                        },
                        "ce:source-text": "Yang C, Siebert JR, Burns R, et al. Heterogeneity of human bone marrow and blood natural killer cells defined by single-cell transcriptome. Nat Commun. 2019; 10 (1): 3931."
                    },
                    {
                        "ref-fulltext": "BaragaÃ±o Raneros A, LÃ³pez-Larrea C, SuÃ¡rez-Ãlvarez B. Acute myeloid leukemia and NK cells: two warriors confront each other. Oncoimmunology. 2019; 8 (2): e1539617.",
                        "@id": "37",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2019"},
                            "ref-title": {"ref-titletext": "Acute myeloid leukemia and NK cells: two warriors confront each other"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "CIT0037",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85060115925",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "8",
                                    "@issue": "2"
                                },
                                "pagerange": {"@first": "e1539617"}
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "A.",
                                    "@_fa": "true",
                                    "ce:surname": "BaragaÃ±o Raneros",
                                    "ce:indexed-name": "Baragano Raneros A."
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "C.",
                                    "@_fa": "true",
                                    "ce:surname": "LÃ³pez-Larrea",
                                    "ce:indexed-name": "Lopez-Larrea C."
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "B.",
                                    "@_fa": "true",
                                    "ce:surname": "SuÃ¡rez-Ãlvarez",
                                    "ce:indexed-name": "Suarez-Alvarez B."
                                }
                            ]},
                            "ref-sourcetitle": "Oncoimmunology"
                        },
                        "ce:source-text": "BaragaÃ±o Raneros A, LÃ³pez-Larrea C, SuÃ¡rez-Ãlvarez B. Acute myeloid leukemia and NK cells: two warriors confront each other. Oncoimmunology. 2019; 8 (2): e1539617."
                    },
                    {
                        "ref-fulltext": "Xu L, Huang Y, Tan L, et al. Increased tim-3 expression in peripheral NK cells predicts a poorer prognosis and tim-3 blockade improves NK cell-mediated cytotoxicity in human lung adenocarcinoma. Int Immunopharmacol. 2015; 29 (2): 635\u2013641.",
                        "@id": "38",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2015"},
                            "ref-title": {"ref-titletext": "Increased tim-3 expression in peripheral NK cells predicts a poorer prognosis and tim-3 blockade improves NK cell-mediated cytotoxicity in human lung adenocarcinoma"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "CIT0038",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "84948461194",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "29",
                                    "@issue": "2"
                                },
                                "pagerange": {
                                    "@first": "635",
                                    "@last": "641"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "L.",
                                        "@_fa": "true",
                                        "ce:surname": "Xu",
                                        "ce:indexed-name": "Xu L."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "Y.",
                                        "@_fa": "true",
                                        "ce:surname": "Huang",
                                        "ce:indexed-name": "Huang Y."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "L.",
                                        "@_fa": "true",
                                        "ce:surname": "Tan",
                                        "ce:indexed-name": "Tan L."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Int Immunopharmacol"
                        },
                        "ce:source-text": "Xu L, Huang Y, Tan L, et al. Increased tim-3 expression in peripheral NK cells predicts a poorer prognosis and tim-3 blockade improves NK cell-mediated cytotoxicity in human lung adenocarcinoma. Int Immunopharmacol. 2015; 29 (2): 635\u2013641."
                    },
                    {
                        "ref-fulltext": "Zheng Y, Li Y, Lian J, et al. TNF-Î±-induced tim-3 expression marks the dysfunction of infltrating natural killer cells in human esophageal cancer. J Transl Med. 2019; 17 (1): 165.",
                        "@id": "39",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2019"},
                            "ref-title": {"ref-titletext": "TNF-Î±-induced tim-3 expression marks the dysfunction of infltrating natural killer cells in human esophageal cancer"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "CIT0039",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85066432329",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "17",
                                    "@issue": "1"
                                },
                                "pagerange": {"@first": "165"}
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "Y.",
                                        "@_fa": "true",
                                        "ce:surname": "Zheng",
                                        "ce:indexed-name": "Zheng Y."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "Y.",
                                        "@_fa": "true",
                                        "ce:surname": "Li",
                                        "ce:indexed-name": "Li Y."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "J.",
                                        "@_fa": "true",
                                        "ce:surname": "Lian",
                                        "ce:indexed-name": "Lian J."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "J Transl Med"
                        },
                        "ce:source-text": "Zheng Y, Li Y, Lian J, et al. TNF-Î±-induced tim-3 expression marks the dysfunction of infltrating natural killer cells in human esophageal cancer. J Transl Med. 2019; 17 (1): 165."
                    },
                    {
                        "ref-fulltext": "Kim N, Kim HS. Targeting checkpoint receptors and molecules for therapeutic modulation of natural killer cells. Front Immunol. 2018; 9 (2041): 2041.",
                        "@id": "40",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2018"},
                            "ref-title": {"ref-titletext": "Targeting checkpoint receptors and molecules for therapeutic modulation of natural killer cells"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "CIT0040",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85053026006",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "9",
                                    "@issue": "2041"
                                },
                                "pagerange": {"@first": "2041"}
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "N.",
                                    "@_fa": "true",
                                    "ce:surname": "Kim",
                                    "ce:indexed-name": "Kim N."
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "H.S.",
                                    "@_fa": "true",
                                    "ce:surname": "Kim",
                                    "ce:indexed-name": "Kim H.S."
                                }
                            ]},
                            "ref-sourcetitle": "Front Immunol"
                        },
                        "ce:source-text": "Kim N, Kim HS. Targeting checkpoint receptors and molecules for therapeutic modulation of natural killer cells. Front Immunol. 2018; 9 (2041): 2041."
                    },
                    {
                        "ref-fulltext": "Xu L, Xu J, Ma S, et al. High tim-3 expression on AML blasts could enhance chemotherapy sensitivity. Oncotarget. 2017; 8 (60): 102088\u2013102096.",
                        "@id": "41",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2017"},
                            "ref-title": {"ref-titletext": "High tim-3 expression on AML blasts could enhance chemotherapy sensitivity"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "CIT0041",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85034829169",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "8",
                                    "@issue": "60"
                                },
                                "pagerange": {
                                    "@first": "102088",
                                    "@last": "102096"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "L.",
                                        "@_fa": "true",
                                        "ce:surname": "Xu",
                                        "ce:indexed-name": "Xu L."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "J.",
                                        "@_fa": "true",
                                        "ce:surname": "Xu",
                                        "ce:indexed-name": "Xu J."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "S.",
                                        "@_fa": "true",
                                        "ce:surname": "Ma",
                                        "ce:indexed-name": "Ma S."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Oncotarget"
                        },
                        "ce:source-text": "Xu L, Xu J, Ma S, et al. High tim-3 expression on AML blasts could enhance chemotherapy sensitivity. Oncotarget. 2017; 8 (60): 102088\u2013102096."
                    },
                    {
                        "ref-fulltext": "Hsu J, Hodgins JJ, Marathe M, et al. Contribution of NK cells to immunotherapy mediated by PD-1/PD-L1 blockade. J Clin Invest. 2018; 128 (10): 4654\u20134668.",
                        "@id": "42",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2018"},
                            "ref-title": {"ref-titletext": "Contribution of NK cells to immunotherapy mediated by PD-1/PD-L1 blockade"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "CIT0042",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85054431178",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "128",
                                    "@issue": "10"
                                },
                                "pagerange": {
                                    "@first": "4654",
                                    "@last": "4668"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "J.",
                                        "@_fa": "true",
                                        "ce:surname": "Hsu",
                                        "ce:indexed-name": "Hsu J."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "J.J.",
                                        "@_fa": "true",
                                        "ce:surname": "Hodgins",
                                        "ce:indexed-name": "Hodgins J.J."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "M.",
                                        "@_fa": "true",
                                        "ce:surname": "Marathe",
                                        "ce:indexed-name": "Marathe M."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "J Clin Invest"
                        },
                        "ce:source-text": "Hsu J, Hodgins JJ, Marathe M, et al. Contribution of NK cells to immunotherapy mediated by PD-1/PD-L1 blockade. J Clin Invest. 2018; 128 (10): 4654\u20134668."
                    },
                    {
                        "ref-fulltext": "Quatrini L, Mariotti FR, Munari E, et al. The immune checkpoint PD-1 in natural killer cells: expression, function and targeting in tumour immunotherapy. Cancers (Basel). 2020; 12 (11): 3285.",
                        "@id": "43",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2020"},
                            "ref-title": {"ref-titletext": "The immune checkpoint PD-1 in natural killer cells: expression, function and targeting in tumour immunotherapy"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "CIT0043",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85095707107",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "12",
                                    "@issue": "11"
                                },
                                "pagerange": {"@first": "3285"}
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "L.",
                                        "@_fa": "true",
                                        "ce:surname": "Quatrini",
                                        "ce:indexed-name": "Quatrini L."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "F.R.",
                                        "@_fa": "true",
                                        "ce:surname": "Mariotti",
                                        "ce:indexed-name": "Mariotti F.R."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "E.",
                                        "@_fa": "true",
                                        "ce:surname": "Munari",
                                        "ce:indexed-name": "Munari E."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Cancers (Basel)"
                        },
                        "ce:source-text": "Quatrini L, Mariotti FR, Munari E, et al. The immune checkpoint PD-1 in natural killer cells: expression, function and targeting in tumour immunotherapy. Cancers (Basel). 2020; 12 (11): 3285."
                    },
                    {
                        "ref-fulltext": "Judge SJ, Dunai C, Aguilar EG, et al. Minimal PD-1 expression in mouse and human NK cells under diverse conditions. J Clin Invest. 2020; 130 (6): 3051\u20133068.",
                        "@id": "44",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2020"},
                            "ref-title": {"ref-titletext": "Minimal PD-1 expression in mouse and human NK cells under diverse conditions"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "CIT0044",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85083699370",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "130",
                                    "@issue": "6"
                                },
                                "pagerange": {
                                    "@first": "3051",
                                    "@last": "3068"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "S.J.",
                                        "@_fa": "true",
                                        "ce:surname": "Judge",
                                        "ce:indexed-name": "Judge S.J."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "C.",
                                        "@_fa": "true",
                                        "ce:surname": "Dunai",
                                        "ce:indexed-name": "Dunai C."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "E.G.",
                                        "@_fa": "true",
                                        "ce:surname": "Aguilar",
                                        "ce:indexed-name": "Aguilar E.G."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "J Clin Invest"
                        },
                        "ce:source-text": "Judge SJ, Dunai C, Aguilar EG, et al. Minimal PD-1 expression in mouse and human NK cells under diverse conditions. J Clin Invest. 2020; 130 (6): 3051\u20133068."
                    }
                ]
            }}
        }
    },
    "affiliation": [
        {
            "affiliation-city": "Bangkok",
            "@id": "60028190",
            "affilname": "Chulalongkorn University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60022183",
            "affilname": "King Chulalongkorn Memorial Hospital",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60022183",
            "affiliation-country": "Thailand"
        }
    ],
    "coredata": {
        "srctype": "j",
        "eid": "2-s2.0-85115990967",
        "dc:description": "Dual targeting of TIM-3 and PD-1/PD-L1 pathways is currently under investigation for cancer immunotherapy. The interaction of these immune checkpoints remains unclear in the leukemic microenvironment of acute myeloid leukemia (AML). We performed an immunophenotypic study of bone marrow in 37 newly diagnosed AML patients. High levels of TIM-3 expression on AML blasts were correlated with first 7 + 3 induction failure (CR 16.2% vs. non-CR 36.4%, p =.038). In contrast, high TIM-3 levels on natural killer (NK) cells were associated with complete remission (CR) status after induction (CR 24.7% vs. non-CR 6.5%, p =.035). Few PD-L1 positive AML blasts and PD-1 or PD-L1 positive NK cells were observed. Although the exhausted PD-1 expressing T cells were detected in 28.3% of T cells, the double positive of PD-1 and TIM-3 T cells were rarely detected. In summary, the TIM-3 levels on AML blasts and NK cells are potentially the prognostic biomarkers in AML.",
        "pubmed-id": "34585994",
        "prism:coverDate": "2022-01-01",
        "prism:aggregationType": "Journal",
        "prism:url": "https://api.elsevier.com/content/abstract/scopus_id/85115990967",
        "dc:creator": {"author": [{
            "ce:given-name": "Thunyamon",
            "preferred-name": {
                "ce:given-name": "Thunyamon",
                "ce:initials": "T.",
                "ce:surname": "Chajuwan",
                "ce:indexed-name": "Chajuwan T."
            },
            "@seq": "1",
            "ce:initials": "T.",
            "@_fa": "true",
            "affiliation": [
                {
                    "@id": "60022183",
                    "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60022183"
                },
                {
                    "@id": "60028190",
                    "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190"
                }
            ],
            "ce:surname": "Chajuwan",
            "@auid": "57279732800",
            "author-url": "https://api.elsevier.com/content/author/author_id/57279732800",
            "ce:indexed-name": "Chajuwan T."
        }]},
        "link": [
            {
                "@_fa": "true",
                "@rel": "self",
                "@href": "https://api.elsevier.com/content/abstract/scopus_id/85115990967"
            },
            {
                "@_fa": "true",
                "@rel": "scopus",
                "@href": "https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85115990967&origin=inward"
            },
            {
                "@_fa": "true",
                "@rel": "scopus-citedby",
                "@href": "https://www.scopus.com/inward/citedby.uri?partnerID=HzOxMe3b&scp=85115990967&origin=inward"
            }
        ],
        "source-id": "26016",
        "citedby-count": "3",
        "prism:volume": "63",
        "subtype": "ar",
        "dc:title": "Characteristics and clinical correlation of TIM-3 and PD-1/PD-L1 expressions in leukemic cells and tumor microenvironment in newly diagnosed acute myeloid leukemia",
        "openaccess": "0",
        "prism:issn": "10292403 10428194",
        "publishercopyright": "Â© 2021 Informa UK Limited, trading as Taylor & Francis Group.",
        "prism:issueIdentifier": "2",
        "subtypeDescription": "Article",
        "prism:publicationName": "Leukemia and Lymphoma",
        "prism:pageRange": "450-456",
        "prism:endingPage": "456",
        "openaccessFlag": "false",
        "prism:doi": "10.1080/10428194.2021.1984454",
        "prism:startingPage": "450",
        "dc:identifier": "SCOPUS_ID:85115990967",
        "dc:publisher": "Taylor and Francis Ltd."
    },
    "idxterms": {"mainterm": [
        {
            "$": "B7-H1 Antigen",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "Hepatitis A Virus Cellular Receptor 2",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "Humans",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "Leukemia, Myeloid, Acute",
            "@weight": "a",
            "@candidate": "n"
        },
        {
            "$": "Programmed Cell Death 1 Receptor",
            "@weight": "a",
            "@candidate": "n"
        },
        {
            "$": "Tumor Microenvironment",
            "@weight": "b",
            "@candidate": "n"
        }
    ]},
    "language": {"@xml:lang": "eng"},
    "authkeywords": {"author-keyword": [
        {
            "@_fa": "true",
            "$": "Acute myeloid leukemia"
        },
        {
            "@_fa": "true",
            "$": "immune checkpoint"
        },
        {
            "@_fa": "true",
            "$": "programmed cell death 1"
        },
        {
            "@_fa": "true",
            "$": "programmed cell death ligand 1"
        },
        {
            "@_fa": "true",
            "$": "T cell immunoglobulin and mucin-domain containing-3"
        }
    ]},
    "subject-areas": {"subject-area": [
        {
            "@_fa": "true",
            "$": "Hematology",
            "@code": "2720",
            "@abbrev": "MEDI"
        },
        {
            "@_fa": "true",
            "$": "Oncology",
            "@code": "2730",
            "@abbrev": "MEDI"
        },
        {
            "@_fa": "true",
            "$": "Cancer Research",
            "@code": "1306",
            "@abbrev": "BIOC"
        }
    ]},
    "authors": {"author": [
        {
            "ce:given-name": "Thunyamon",
            "preferred-name": {
                "ce:given-name": "Thunyamon",
                "ce:initials": "T.",
                "ce:surname": "Chajuwan",
                "ce:indexed-name": "Chajuwan T."
            },
            "@seq": "1",
            "ce:initials": "T.",
            "@_fa": "true",
            "affiliation": [
                {
                    "@id": "60022183",
                    "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60022183"
                },
                {
                    "@id": "60028190",
                    "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190"
                }
            ],
            "ce:surname": "Chajuwan",
            "@auid": "57279732800",
            "author-url": "https://api.elsevier.com/content/author/author_id/57279732800",
            "ce:indexed-name": "Chajuwan T."
        },
        {
            "ce:given-name": "Patsita",
            "preferred-name": {
                "ce:given-name": "Patsita",
                "ce:initials": "P.",
                "ce:surname": "Kansuwan",
                "ce:indexed-name": "Kansuwan P."
            },
            "@seq": "2",
            "ce:initials": "P.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60022183",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60022183"
            },
            "ce:surname": "Kansuwan",
            "@auid": "57278650400",
            "author-url": "https://api.elsevier.com/content/author/author_id/57278650400",
            "ce:indexed-name": "Kansuwan P."
        },
        {
            "ce:given-name": "Sirorat",
            "preferred-name": {
                "ce:given-name": "Sirorat",
                "ce:initials": "S.",
                "ce:surname": "Kobbuaklee",
                "ce:indexed-name": "Kobbuaklee S."
            },
            "@seq": "3",
            "ce:initials": "S.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60022183",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60022183"
            },
            "ce:surname": "Kobbuaklee",
            "@auid": "57211805681",
            "author-url": "https://api.elsevier.com/content/author/author_id/57211805681",
            "ce:indexed-name": "Kobbuaklee S."
        },
        {
            "ce:given-name": "Chantiya",
            "preferred-name": {
                "ce:given-name": "Chantiya",
                "ce:initials": "C.",
                "ce:surname": "Chanswangphuwana",
                "ce:indexed-name": "Chanswangphuwana C."
            },
            "@seq": "4",
            "ce:initials": "C.",
            "@_fa": "true",
            "affiliation": [
                {
                    "@id": "60022183",
                    "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60022183"
                },
                {
                    "@id": "60028190",
                    "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190"
                }
            ],
            "ce:surname": "Chanswangphuwana",
            "@auid": "55503235900",
            "author-url": "https://api.elsevier.com/content/author/author_id/55503235900",
            "ce:indexed-name": "Chanswangphuwana C."
        }
    ]}
}}